Carcinogenesis Advance Access published online on November 25, 2004
Carcinogenesis, doi:10.1093/carcin/bgh343
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Epidemiology and Biostatistics, University of South Carolina, Arnold School of Public Health, Columbia, SC; South Carolina Cancer Center, Columbia, SC
* To whom correspondence should be addressed. Peroxisome proliferator-activated receptor
Revised October 18, 2004
Accepted November 17, 2004
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION
The PPAR
Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas
2 Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA
3 South Carolina Cancer Center, Columbia, SC; Department of Pathology, University of South Carolina School of Medicine, Columbia, SC
4 Department of Epidemiology and Biostatistics, University of South Carolina, Arnold School of Public Health, Columbia, SC; South Carolina Cancer Center, Columbia, SC; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
Dawen Xie, E-mail: dawen.xie{at}PalmettoHealth.org
![]()
Abstract
(PPAR
), a member of the nuclear hormone receptor superfamily initially shown to be a key regulator of fat cell differentiation, can inhibit cell growth and induce apoptosis in colon cell lines. There are heterozygous loss-of-function mutations in the gene encoding PPAR
in tumors from
10% of human colon cancer patients. A common structural polymorphism has been detected in the PPAR
gene at codon 12 (Pro12Ala). We investigated the hypothesis that the PPAR
Pro12Ala polymorphism is associated with colorectal adenoma risk in a recently concluded case-control study of incident sporadic colorectal adenomas (163 cases and 212 controls). The multivariate-adjusted odds ratio (OR) for incident sporadic colorectal adenoma was 0.65 (95% CI: 0.39-1.09) for those with Pro12Ala or Ala12Ala genotypes compared to those with the Pro12Pro genotype. Multivariate-adjusted inverse associations with the Ala12 variant were more pronounced among those who were female (OR: 0.36; 95% CI: 0.18-0.75) or did not take NSAIDs (OR: 0.38; 95% CI: 0.14-1.00). Marginally significant results were observed among those with a lower waist:hip ratio (OR: 0.52; 95% CI: 0.24-1.12) or a lower body mass index (OR: 0.46; 95%: 0.20-1.05). Smoking was a very strong risk factor (OR: 2.34; 95%CI: 1.37-4.02) for colorectal adenoma among those with wild type (Pro12Pro), but not those with the Ala12 variant (OR: 0.86; 95%CI: 0.35-2.09). Larger studies are needed to validate these results, which suggest that the PPAR
Pro12Ala polymorphism may interact with other factors to protect against colorectal adenoma.![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. N. Prasad, A. Saxena, U. C. Ghoshal, M. R. Bhagat, and N. Krishnani Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease Ann. Onc., July 1, 2008; 19(7): 1299 - 1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Chang, A. Rashid, Y.-T. Gao, G. Andreotti, M.-C. Shen, B.-S. Wang, T.-Q. Han, B.-H. Zhang, L. C. Sakoda, M. F. Leitzmann, et al. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China Carcinogenesis, May 1, 2008; 29(5): 944 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-P. Koh, J.-M. Yuan, D. Van Den Berg, S. A. Ingles, and M. C. Yu Peroxisome proliferator-activated receptor (PPAR) {gamma} gene polymorphisms and colorectal cancer risk among Chinese in Singapore Carcinogenesis, September 1, 2006; 27(9): 1797 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Gunter, F. Canzian, S. Landi, S. J. Chanock, R. Sinha, and N. Rothman Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1126 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Huber, E.-K. Bentz, C. Schneeberger, J. C. Huber, L. Hefler, and C. Tempfer Ten Polymorphisms of Estrogen-Metabolizing Genes and a Family History of Colon Cancer--An Association Study of Multiple Gene-Gene Interactions Reproductive Sciences, October 1, 2005; 12(7): e51 - e54. [Abstract] [PDF] |
||||



